8,502 results on '"Liver Cirrhosis, Biliary"'
Search Results
2. IDEAL: Intended to Determine the Effects of Seladelpar on Normalization of Alkaline Phosphatase Levels in Subjects With Primary Biliary Cholangitis (PBC) and an Incomplete Response or Intolerance to Ursodeoxycholic Acid (UDCA) (IDEAL)
3. A Study Observing Everyday Effectiveness and Safety of the Drug Elafibranor in Participants With Primary Biliary Cholangitis Who Are Receiving Ongoing Treatment (ELFINITY)
4. Evidence Based Mental Wellness Programming Online for Adults Across Chronic Physical Conditions (EMPOwer)
5. Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis (AFFIRM)
6. Study to Evaluate the Safety, Tolerability, PDs, and Efficacy of CNP-104 in Subjects With Primary Biliary Cholangitis
7. Seladelpar in Subjects With Primary Biliary Cholangitis (PBC)
8. An Open-Label Study Following Oral Dosing of Seladelpar to Subjects With Primary Biliary Cholangitis (PBC) and Hepatic Impairment (HI)
9. Study to Evaluate EP547 in Subjects With Cholestatic Pruritus Due to Primary Biliary Cholangitis or Primary Sclerosing Cholangitis (PACIFIC)
10. A Study to Evaluate the Pharmacokinetics and Safety of K-808 (Pemafibrate) in Subjects With Primary Biliary Cholangitis With Compensated Cirrhosis and Without Cirrhosis.
11. To Evaluate Safety and Tolerability of the Fixed- Dose Combination of Obeticholic Acid and Bezafibrate
12. A Study to Evaluate Efficacy and Safety of an Investigational Drug Named Volixibat in Patients With Itching Caused by Primary Biliary Cholangitis (VANTAGE)
13. A Study of Elafibranor in Adults With Primary Biliary Cholangitis and Inadequate Response or Intolerance to Ursodeoxycholic Acid. (ELSPIRE)
14. Study of Elafibranor in Patients With Primary Biliary Cholangitis (PBC) (ELATIVE)
15. Linerixibat Long-term Safety, and Tolerability Study (LLSAT)
16. Study to Evaluate the Safety and Efficacy of ASC42 Tablets in Subjects With Primary Biliary Cholangitis
17. PET/CT Scans Using the Tracer 11C-Csar, a Bile Acid Analog, to Depict and Visualize Changes in the Hepatobiliary System in Patients With Primary Biliary Cholangitis Before and After Treatment.
18. Fenofibrate in Patients with Primary Biliary Cholangitis (PBC)
19. A Pilot Study of Fenofibrate and Ursodeoxycholic Acid in the Treatment of Newly Diagnosed Primary Biliary Cholangitis
20. Global Linerixibat Itch Study of Efficacy and Safety in Primary Biliary Cholangitis (PBC) (GLISTEN)
21. A Multicenter, Randomized, Controlled Trial of Prednisone Combined with Ursodeoxycholic Acid in the Treatment of Primary Biliary Cholangitis with Moderate to Severe Interface Hepatitis Characteristics
22. Study to Evaluate Safety, Tolerability and Efficacy of Saroglitazar Mg in Patients With Primary Biliary Cholangitis (EPICS)
23. Open-Label Extension Study of Saroglitazar Magnesium in Participants with Primary Biliary Cholangitis
24. Saroglitazar Magnesium for Treatment of Primary Biliary Cholangitis (EPICS-III)
25. Study to Evaluate the Efficacy and Safety of K-808 (Pemafibrate) in Participants with Primary Biliary Cholangitis (PBC) with Inadequate Response to Ursodeoxycholic Acid (UDCA) And/or Obeticholic Acid (OCA) Treatment.
26. TruGraf Liver Gene Expression Serial Test
27. RESPONSE: Response to Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and an Inadequate Control to or an Intolerance to Ursodeoxycholic Acid (UDCA)
28. A Trial of Setanaxib in Patients With Primary Biliary Cholangitis (PBC) and Liver Stiffness (TRANSFORM)
29. Liver-gut Axis Study Through Identification of Liver Disease-specific Microbiome (LGAS)
30. Efficacy and Safety of Obeticholic Acid in the Treatment of Primary Biliary Cholangitis
31. Genomic Resources for Enhancing Available Therapies (GREAT1.0) Study (GREAT1)
32. Study of OCA in Combination With BZF Evaluating Efficacy, Safety, and Tolerability in Participants With PBC
33. Study of OCA in Combination With BZF Evaluating Efficacy, Safety and Tolerability in Participants With PBC
34. Umbilical Cord Derived Mesenchymal Stem Cell (UC -MSC) Transplantation for Children Suffering From Biliary Atresia (UCMSCBA)
35. Autologous Bone Marrow Mononuclear Stem Cell for Children Suffering From Liver Cirrhosis Due to Biliary Atresia
36. Efficacy and Safety of Bezafibrate 400 mg and Bezafibrate 200 mg as Adjunctive Treatments in Patients With Primary Biliary Cholangitis and Non-optimal Biochemical Response to Ursodeoxycholic Acid Therapy (BEZURSO 2)
37. Preliminary Clinical Study of UTAA09 Injection in the Treatment of Relapsed/Refractory Autoimmune Diseases
38. Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States (LCN RESCU)
39. Clinical Study on the Treatment of Elevated Total Bilirubin in Primary Biliary Cholangitis With Baobao Dan Capsule
40. Fenofibrate for Compensated Cirrhosis Patients With Primary Biliary Cholangitis
41. Open-Label Study of HTD1801 in Adult Subjects With Primary Biliary Cholangitis (PRONTO-PBC)
42. Genetic Epidemiology of Primary Biliary Cirrhosis (PBC)
43. Biobank for Cholestatic Liver Diseases.
44. The Effectiveness of Combining Ursodeoxycholic Acid With Vitamin D in Treating Patients With Primary Biliary Cholangitis
45. An Open Label, Single-dose, Single Period ADME Study of A4250 in Healthy Subjects
46. A Safety and Pharmakokinetic Study of A4250 Alone or in Combination With A3384
47. Early Identification of Myocardial Impairment in PBC (EARLY-MYO-PBC)
48. A 5-year Longitudinal Observational Study of Patients With Primary Biliary Cholangitis
49. Trial of Psychoeducational and Hypnosis Interventions on the Fatigue Associated With PBC in Women (CBP-HOPE)
50. Combination Antiretroviral Therapy (cART) for PBC
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.